iPierian's Series C Round

iPierian raised a round of funding on September 04, 2013.

iPierian is a biotechnology company developing therapies for neurodegenerative disease, specifically focused on discovering monoclonal antibodies against targets of the Tau protein for treatment of Al…

Articles about iPierian's Series C Round: